Dusseldorf - Delayed Quote EUR

Mirum Pharmaceuticals Inc (08D.DU)

22.40 +0.20 (+0.90%)
As of 12:30 PM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
186,374.00
186,374.00
77,062.00
19,138.00
--
Cost of Revenue
47,039.00
47,039.00
12,374.00
1,903.00
--
Gross Profit
139,335.00
139,335.00
64,688.00
17,235.00
--
Operating Expense
248,489.00
248,489.00
195,908.00
190,648.00
104,296.00
Operating Income
-109,154.00
-109,154.00
-131,220.00
-173,413.00
-104,296.00
Net Non Operating Interest Income Expense
-1,370.00
-1,370.00
-12,122.00
-17,224.00
1,224.00
Other Income Expense
-51,900.00
-51,900.00
1,271.00
106,686.00
-192.00
Pretax Income
-162,424.00
-162,424.00
-142,071.00
-83,951.00
-103,264.00
Tax Provision
991.00
991.00
-6,406.00
37.00
6.00
Net Income Common Stockholders
-163,415.00
-163,415.00
-135,665.00
-83,988.00
-103,270.00
Average Dilution Earnings
--
--
-914.00
--
--
Diluted NI Available to Com Stockholders
-163,415.00
-163,415.00
-136,579.00
-83,988.00
-103,270.00
Basic EPS
-4.00
-4.00
-4.01
-2.77
-4.09
Diluted EPS
-4.00
-4.00
-4.02
-2.77
-4.09
Basic Average Shares
40,885.12
40,885.12
33,839.07
30,321.72
25,251.97
Diluted Average Shares
40,885.12
40,885.12
33,982.49
30,321.72
25,251.97
Total Operating Income as Reported
-109,154.00
-109,154.00
-131,220.00
-173,413.00
-104,296.00
Total Expenses
295,528.00
295,528.00
208,282.00
192,551.00
104,296.00
Net Income from Continuing & Discontinued Operation
-163,415.00
-163,415.00
-135,665.00
-83,988.00
-103,270.00
Normalized Income
-124,644.96
-124,644.96
-136,530.14
-83,453.64
-103,270.00
Interest Income
13,735.00
13,735.00
3,857.00
366.00
1,559.00
Interest Expense
15,105.00
15,105.00
15,979.00
17,590.00
335.00
Net Interest Income
-1,370.00
-1,370.00
-12,122.00
-17,224.00
1,224.00
EBIT
-147,319.00
-147,319.00
-126,092.00
-66,361.00
-102,929.00
EBITDA
-136,490.00
-136,490.00
-122,854.00
-65,766.00
-102,306.00
Reconciled Cost of Revenue
47,039.00
47,039.00
12,374.00
1,903.00
--
Reconciled Depreciation
10,829.00
10,829.00
3,238.00
595.00
623.00
Net Income from Continuing Operation Net Minority Interest
-163,415.00
-163,415.00
-135,665.00
-83,988.00
-103,270.00
Total Unusual Items Excluding Goodwill
-49,076.00
-49,076.00
906.00
-732.00
--
Total Unusual Items
-49,076.00
-49,076.00
906.00
-732.00
--
Normalized EBITDA
-87,414.00
-87,414.00
-123,760.00
-65,034.00
-102,306.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-10,305.96
-10,305.96
40.86
-197.64
--
12/31/2020 - 10/7/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade